ALGNAlign Technology

$159.28

Is the price fair?

What ALGN's price assumes

Align Technology trades at 26.8× earnings against 42.5× for the median Medical Instruments & Supplies name, cheaper than its own group.

26.8

Trailing P/E · Medical Instruments & Supplies median 42.5 · cheaper than the typical name in its group

Price / sales
3.00

Price / sales · as of 2026-Q1

Free cash flow yield
4.5%

Free cash flow yield · Medical Instruments & Supplies median 3.7%

Growth the price implies
+7.1%

Growth the price implies · The price pays for +7.1% free cash flow growth a year for a decade; the business has delivered +7.5% a year over the last three.

Details
Price / book2026-Q1
2.96
Healthcare median P/E362 names
31.5
Medical Instruments & Supplies median P/E29 names
42.5
Free cash flow, trailing twelve months
$584M
Market capitalisation
$13.0B
3-year revenue growth
+3.4%
3-year free cash flow growth
+7.5%
What the market has paid for these earnings: 37 quarters of its own multiple × $5.95 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$224.07
Its own P/E history, median$284.98
Its own P/E history, upper quartile$385.16
52-week range$124.88 – $197.51
Today$159.28

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.